Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
5,941,843
-
Shares change
-
+2,865,875
-
Total reported value, excl. options
-
$74,429,183
-
Value change
-
+$40,638,979
-
Put/Call ratio
-
146%
-
Number of buys
-
31
-
Number of sells
-
-14
-
Price
-
$12.55
Significant Holders of PDS Biotechnology Corp - Common (PDSB) as of Q2 2021
57 filings reported holding PDSB - PDS Biotechnology Corp - Common as of Q2 2021.
PDS Biotechnology Corp - Common (PDSB) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,941,843 shares
of 49,594,356 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (1,499,149 shares), VANGUARD GROUP INC (963,502 shares), RENAISSANCE TECHNOLOGIES LLC (455,457 shares), BlackRock Inc. (401,422 shares), Worth Venture Partners, LLC (348,703 shares), EAM Investors, LLC (279,613 shares), INSPIRION WEALTH ADVISORS, LLC (253,262 shares), EAM Global Investors LLC (187,900 shares), GEODE CAPITAL MANAGEMENT, LLC (177,925 shares), and FIRST MANHATTAN CO (172,931 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.